These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 2957235

  • 1. Treatment of leiomyomata uteri with D-Trp6-luteinizing hormone-releasing hormone.
    Perl V, Marquez J, Schally AV, Comaru-Schally AM, Leal G, Zacharias S, Gomez-Lira C.
    Fertil Steril; 1987 Sep; 48(3):383-9. PubMed ID: 2957235
    [Abstract] [Full Text] [Related]

  • 2. Treatment of uterine leiomyomata with a luteinizing hormone-releasing hormone agonist: the possibility of nonsurgical management in selected perimenopausal women.
    Nakamura Y, Yoshimura Y, Yamada H, Ubukata Y, Ando M, Suzuki M.
    Fertil Steril; 1991 May; 55(5):900-5. PubMed ID: 1902420
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of a gonadotropin-releasing hormone agonist in the treatment of uterine leiomyomata: long-term follow-up.
    Letterie GS, Coddington CC, Winkel CA, Shawker TH, Loriaux DL, Collins RL.
    Fertil Steril; 1989 Jun; 51(6):951-6. PubMed ID: 2498132
    [Abstract] [Full Text] [Related]

  • 4. Rapid reduction of uterine leiomyomas with monthly injections of D-Trp6-GnRH.
    van Leusden HA, Dogterom AA.
    Gynecol Endocrinol; 1988 Mar; 2(1):45-51. PubMed ID: 2972173
    [Abstract] [Full Text] [Related]

  • 5. D-Trp-6-luteinizing hormone-releasing hormone microcapsules in the treatment of uterine leiomyomas.
    Golan A, Bukovsky I, Schneider D, Ron-el R, Herman A, Caspi E.
    Fertil Steril; 1989 Sep; 52(3):406-11. PubMed ID: 2528476
    [Abstract] [Full Text] [Related]

  • 6. Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: assessment by magnetic resonance imaging.
    Andreyko JL, Blumenfeld Z, Marshall LA, Monroe SE, Hricak H, Jaffe RB.
    Am J Obstet Gynecol; 1988 Apr; 158(4):903-10. PubMed ID: 2966587
    [Abstract] [Full Text] [Related]

  • 7. An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.
    Carr BR, Marshburn PB, Weatherall PT, Bradshaw KD, Breslau NA, Byrd W, Roark M, Steinkampf MP.
    J Clin Endocrinol Metab; 1993 May; 76(5):1217-23. PubMed ID: 8496313
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp6 analogue of luteinizing hormone-releasing hormone.
    Redding TW, Schally AV.
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6509-12. PubMed ID: 6458815
    [Abstract] [Full Text] [Related]

  • 9. Luteinizing hormone-releasing hormone agonist and uterine leiomyoma: a pilot study.
    Maheux R, Guilloteau C, Lemay A, Bastide A, Fazekas AT.
    Am J Obstet Gynecol; 1985 Aug 15; 152(8):1034-8. PubMed ID: 3927734
    [Abstract] [Full Text] [Related]

  • 10. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
    Murphy AA, Kettel LM, Morales AJ, Roberts VJ, Yen SS.
    J Clin Endocrinol Metab; 1993 Feb 15; 76(2):513-7. PubMed ID: 8432797
    [Abstract] [Full Text] [Related]

  • 11. Two-step gonadotropin-releasing hormone agonist treatment of uterine leiomyomas: standard-dose therapy followed by reduced-dose therapy.
    Broekmans FJ, Hompes PG, Heitbrink MA, Netelenbos CC, Roos JC, Falke TM, Schoemaker J.
    Am J Obstet Gynecol; 1996 Nov 15; 175(5):1208-16. PubMed ID: 8942490
    [Abstract] [Full Text] [Related]

  • 12. Pre-surgical treatment of uterine myomas with LH-RH agonists.
    D'Addato F, Repinto A, Andreoli C.
    Clin Exp Obstet Gynecol; 1992 Nov 15; 19(1):45-50. PubMed ID: 1535032
    [Abstract] [Full Text] [Related]

  • 13. Long-acting gonadotropin hormone-releasing hormone analog used to treat uteri.
    Coddington CC, Collins RL, Shawker TH, Anderson R, Loriaux DL, Winkel CA.
    Fertil Steril; 1986 May 15; 45(5):624-9. PubMed ID: 3084300
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of the growth of some hormone dependent tumors by D-Trp6-LH-RH.
    Schally AV, Redding TW, Comaru-Schally AM.
    Med Oncol Tumor Pharmacother; 1984 May 15; 1(2):109-18. PubMed ID: 6242477
    [Abstract] [Full Text] [Related]

  • 15. Regression of leiomyomata uteri following hypoestrogenism induced by repetitive luteinizing hormone-releasing hormone agonist treatment: preliminary report.
    Maheux R, Guilloteau C, Lemay A, Bastide A, Fazekas AT.
    Fertil Steril; 1984 Oct 15; 42(4):644-6. PubMed ID: 6436065
    [No Abstract] [Full Text] [Related]

  • 16. Long-term use of an LH-RH agonist in the management of uterine leiomyomas: a study of 17 cases.
    George M, Lhomme C, Lefort J, Gras C, Comaru-Schally AM, Schally AV.
    Int J Fertil; 1989 Oct 15; 34(1):19-24. PubMed ID: 2565299
    [Abstract] [Full Text] [Related]

  • 17. Treatment of uterine leiomyomas in perimenopausal women with gonadotropin-releasing hormone agonists.
    Nakamura Y, Yoshimura Y.
    Clin Obstet Gynecol; 1993 Sep 15; 36(3):660-7. PubMed ID: 8403612
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.